A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

被引：0
|
作者：
Zhen, Changqing [1 ]
Ding, Mei [1 ]
Lu, Kang [1 ]
Ge, Xueling [1 ]
Chen, Na
Fang, Xiaosheng [1 ]
Sui, Xiaohui [1 ]
Jiang Yujie [1 ]
Liu, Xin [1 ]
Li, Ying [1 ]
Wang, Xianghua [1 ]
Li, Ying [1 ]
Zhang, Lingyan [1 ]
Xu, Hongzhi [1 ]
Fan, Juan [1 ]
Wang, Xin [1 ]
机构：
[1] Shandong Univ, Dept Hematol, Shandong Prov Hosp, Jinan, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5323
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma
    Dias, Catarina
    Isenberg, David A.
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (06) : 360 - 368
  • [32] Clinical Features and Prognosis of Patients with COVID-19 and B-Cell Non-Hodgkin Lymphoma
    Lin, Ya-Qing
    Li, Na
    Wu, Yan-Li
    Ma, Jin-Bao
    Gao, Hai-Nv
    Zhang, Xuan
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4501 - 4510
  • [33] A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF PEG-G-CSF IN CANCER PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA.
    Li, Z.
    Jin, W.
    Mei, H.
    Qi, W.
    Hua, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S40 - S40
  • [34] INOTUZUMAB OZOGAMICIN IN PATIENTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA REFRACTORY TO RITUXIMAB AND CHEMOTHERAPY OR RADIOIMMUNOTHERAPY
    Goy, A.
    Leach, J.
    Tsai, M.
    Foran, J.
    Forero, A.
    Wagner-Johnston, N.
    Ehmann, C.
    Egyed, M.
    Ando, K.
    Hatake, K.
    Tobinai, K.
    Feldman, T.
    Vandendries, E.
    Volkert, A.
    Wang, S. L.
    Ogura, M.
    HAEMATOLOGICA, 2012, 97 : 324 - 324
  • [35] Disease characteristics, treatment and clinical outcomes of patients with B-cell non-Hodgkin lymphoma: A retrospective study in Taiwan
    Pei, Sung-Nan
    Qiu, Hong
    Rothwell, Lee Anne
    Liu, Yanfang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 41 - 41
  • [36] Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma
    Ansell, Stephen M.
    Witzig, Thomas E.
    Inwards, David J.
    Porrata, Luis F.
    Ythier, Arnaud
    Ferrande, Lee
    Nestorov, Ivan
    Devries, Todd
    Dillon, Stacey R.
    Hausman, Diana
    Novak, Anne J.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1105 - 1110
  • [37] Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data
    Zhao, Jie
    Qiao, Gaoxing
    Liang, Yan
    Li, Jia
    Hu, Wei
    Zuo, Xu
    Li, Junfang
    Zhao, Chenglong
    Zhang, Xiaojian
    Du, Shuzhang
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [38] Factors Associated with Chemotherapy-induced Neutropenia in Diffuse Large B-cell Lymphoma Patients Undergoing Combination Chemotherapy: A Case-Control Study
    Lim, Su Yeon
    Choi, Ja Yun
    ASIAN ONCOLOGY NURSING, 2022, 22 (03) : 153 - 162
  • [39] Ultrastructure of blood leukocytes in the treatment of chemotherapy-induced myelosuppression in children with non-Hodgkin's lymphomas using rhG-CSF (Filgrastim)
    Butenko, AK
    Afanasyeva, VV
    Glukhovskaya, IY
    Klimnyuk, GI
    Balitskaya, OV
    Zak, KP
    EXPERIMENTAL ONCOLOGY, 1997, 19 (02): : 147 - 152
  • [40] Factors Influencing Chemotherapy-Induced Nausea, Vomiting, and Alterations in Taste in Patients with Non-Hodgkin Lymphoma
    Talas, Melek Serpil
    Kurt, Berna
    Kayikci, Eda Gul
    Dal, Mehmet Sinan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025,
12345